Shunrenka subcutaneous injection 463.5mg contains lenacapavir sodium and is manufactured by Gilead Science. It is an injectable drug with YJ code 6250410A1025 and a standard of 1 set of 2 1.5mL bottles.
Shunrenka subcutaneous injection 463.5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →